Xiaoyang Lin Selected Research

Xiaoyang Lin Research Topics

Disease

22	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 02/2008
7	Cognitive Dysfunction 01/2022 - 01/2009
6	Inflammation (Inflammations) 01/2020 - 02/2008
4	Parkinson Disease (Parkinson's Disease) 05/2019 - 01/2015
3	Meningoencephalitis 01/2020 - 02/2008
3	Neoplasms (Cancer) 01/2020 - 01/2014
2	Dementia (Dementias) 10/2016 - 01/2012
2	Neuroinflammatory Diseases 01/2015 - 07/2013
2	Neuroblastoma 12/2012 - 01/2011
1	Nervous System Diseases (Neurological Disorders) 04/2022
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2022
1	COVID-19 01/2022
1	Disease Progression 03/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2020
1	Amyloidosis 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2018
1	Pain (Aches) 01/2016
1	Memory Disorders (Memory Loss) 01/2014
1	Lewis Lung Carcinoma 01/2014
1	Neutropenia 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2011

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2022 - 02/2008
7	Amyloid beta-PeptidesIBA 09/2012 - 02/2008
6	Peptides (Polypeptides)IBA 01/2022 - 02/2008
6	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 05/2019 - 01/2011
6	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 01/2009
4	CytokinesIBA 01/2022 - 02/2008
4	Coffee FDA Link 01/2019 - 01/2009
3	Dronabinol (THC)FDA LinkGeneric 04/2022 - 01/2014
2	Therapeutic UsesIBA 03/2022 - 01/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2020 - 01/2012
2	AN-1792IBA 01/2020 - 09/2012
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 01/2014
2	EnzymesIBA 11/2015 - 01/2014
2	SynucleinsIBA 01/2015 - 01/2015
2	FlavonoidsIBA 01/2014 - 01/2011
2	MelatoninIBA 12/2012 - 08/2009
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2011 - 01/2009
2	Drinking WaterIBA 08/2009 - 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	EpitopesIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2020
1	gambogic acidIBA 01/2020
1	Circular RNAIBA 01/2020
1	ArginaseIBA 01/2020
1	alpha-SynucleinIBA 05/2019
1	Neuroprotective AgentsIBA 01/2019
1	Amyloidogenic ProteinsIBA 01/2019
1	Liposomes (Liposome)IBA 11/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 11/2018
1	PolymersIBA 01/2016
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Peptide FragmentsIBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2015
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2015
1	Protein Subunit VaccinesIBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2014
1	Dinoprostone (PGE2)FDA Link 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	AntibodiesIBA 01/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2013
1	Monocyte Chemoattractant ProteinsIBA 07/2013
1	Messenger RNA (mRNA)IBA 07/2013
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2012
1	Purinergic P1 Receptor AntagonistsIBA 12/2012
1	SuspensionsIBA 09/2012
1	AntigensIBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2011
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	TeaIBA 01/2011
1	Presenilin-1IBA 01/2009
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2008
1	saponin QA-21V1 (QS21)IBA 02/2008

Therapy/Procedure

2	Immunotherapy 05/2019 - 09/2012
2	Therapeutics 11/2015 - 08/2009
1	Aftercare (After-Treatment) 03/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022
1	Analgesia 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2012
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2012
1	Oral Administration 08/2009